Carlos Palacio
Endocrinology, Diabetes & Metabolism · Zephyrhills, FLNPI 1679742993
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,672 and has fallen 98.3% since, to $28 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in FL, where the typical reported total is $3,445.
Across 209 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$611
- Sanofi-aventis U.S. LLC$420
- AstraZeneca$387
- Boehringer Ingelheim$283
- Medtronic$229
- Merck$217
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,09296%
- Gifts$1194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 65 | $611 |
| Sanofi-aventis U.S. LLC | 30 | $420 |
| AstraZeneca | 22 | $387 |
| Boehringer Ingelheim | 19 | $283 |
| Medtronic(2 entities) | 6 | $229 |
| Merck | 19 | $217 |
| Mannkind Corporation | 6 | $196 |
| Lilly USA, LLC | 10 | $182 |
| BETA Bionics, Inc. | 1 | $88 |
| Dexcom, Inc. | 4 | $78 |
| IBSA Pharma Inc. | 4 | $72 |
| Abbott | 4 | $63 |
| Antares Pharma, Inc. | 4 | $62 |
| Insulet Corporation | 2 | $60 |
| Corcept Therapeutics | 2 | $50 |
| Valeritas, Inc. | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $35 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Grifols USA, LLC | 1 | $28 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| AbbVie | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$145
How this compares
$3,211 in reported general payments places this provider in the 45th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Other endocrinology, diabetes & metabolism in Zephyrhills
- Jay SkylerMiami$2.2M
- Arelis MaderaPort Charlotte$1.7M
- Damon TantonOrlando$1.2M
- Gaston PonteMelbourne$906K
- Brian LakeLargo$888K
- David SuttonJacksonville$783K
- Mae Sheikh AliJacksonville$751K
- Richard PratleyOrlando$735K
- Lee MetchickDeland$728K
- Misha DenhamCoral Gables$673K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.